You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PH 2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Group 2 Pulmonary Hypertension, Heart Failure Trial (Gradient Denervation System)

Not yet recruiting
  • Group 2 Pulmonary Hypertension
  • Heart Failure
  • Gradient Denervation System
  • (no location specified)
Sep 18, 2023

Stomach Cancer, Adenocarcinoma Trial in Seoul (Durvalumab, Savolitinib)

Recruiting
  • Stomach Cancer, Adenocarcinoma
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 10, 2023

Diabete Type 2, Obesity Trial in Orlando (HU6)

Not yet recruiting
  • Diabete Type 2
  • Obesity
  • Orlando, Florida
    AdventHealth Translational Research Institute
Oct 23, 2023

SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19 Trial (Bivalent BNT162b2 (original/Omicron

Not yet recruiting
  • SARS-CoV-2 Virus
  • +2 more
  • Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose
  • +4 more
  • (no location specified)
Sep 14, 2022

Type 2 Diabetes Trial (behavioral, device, other)

Not yet recruiting
  • Type 2 Diabetes
  • Acceptance and Commitment Therapy
  • +2 more
  • (no location specified)
Sep 5, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,

Active, not recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Zhengzhou, Henan, China
    Henan cancer hospital
Jun 23, 2023

Non-Alcoholic Fatty Liver Disease, Type 2 Diabetes, Obesity Trial in United States (HU6, Placebo)

Not yet recruiting
  • Non-Alcoholic Fatty Liver Disease
  • +3 more
  • Montclair, California
  • +5 more
Jul 31, 2023

COVID-19 Trial in United States (VXA-CoV2-1.1-S, Placebo Tablets)

Recruiting
  • COVID-19
  • Long Beach, California
  • +3 more
Sep 19, 2022

Glioblastoma Multiforme, Glycolytic Index, Epidermal Growth Factor Receptor Trial (pH Measurement of in vivo tissue)

Not yet recruiting
  • Glioblastoma Multiforme
  • +2 more
  • pH Measurement of in vivo tissue
  • (no location specified)
Sep 26, 2023

Diagnostic Test Trial in Sacramento (Measuring of analytes)

Recruiting
  • Diagnostic Test
  • Measuring of analytes
  • Sacramento, California
    UC Davis
Oct 9, 2023

Heart Failure With Preserved Ejection Fraction Trial (HU6, Placebo)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Hialeah, Florida
  • +3 more
Dec 19, 2022

Multiple Myeloma Trial (GPC-100, Propranolol, G-CSF)

Not yet recruiting
  • Multiple Myeloma
  • (no location specified)
Sep 29, 2022

Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

Not yet recruiting
  • Stomach Neoplasm
  • (no location specified)
Oct 16, 2023

Hypertension, Pulmonary Trial in Germany, United Kingdom (Blood Sample, Cardiac MRI)

Completed
  • Hypertension, Pulmonary
  • Blood Sample
  • Cardiac MRI
  • Bonn, Germany
  • +7 more
Aug 16, 2022

Heart Failure, Pulmonary Hypertension Trial in Vancouver, Ottawa (Rivet Shunt)

Not yet recruiting
  • Heart Failure
  • Pulmonary Hypertension
  • Rivet Shunt
  • Vancouver, British Columbia, Canada
  • +1 more
Sep 26, 2022

Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Kidney Diseases Trial in Worldwide (DCR-PHXC)

Enrolling by invitation
  • Primary Hyperoxaluria Type 1 (PH1)
  • +5 more
  • San Francisco, California
  • +19 more
Jun 22, 2022

Female Subjects Undergoing COH in ART to Prevent Early Ovulation Trial in Beijing (SHR7280 tablets)

Active, not recruiting
  • Female Subjects Undergoing COH in ART to Prevent Early Ovulation
  • SHR7280 tablets
  • Beijing, Beijing, China
    Peking University Third Hospital
Oct 11, 2022

Breast Cancer Trial in New Haven (Everolimus)

Terminated
Has Results
  • Breast Cancer
  • New Haven, Connecticut
    Yale University
Jan 12, 2022

Thrombocythemia, Essential Trial in San Antonio (IMG-7289)

Recruiting
  • Thrombocythemia, Essential
  • San Antonio, Texas
    Mays Cancer Center
Dec 14, 2021

Phosphorus Metabolism Disorders, Acid-Base Balance Disorder Trial in Warsaw (Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35

Completed
  • Phosphorus Metabolism Disorders
  • Acid-Base Balance Disorder
  • Group 1: B) Dbic 35 -30 mmol/L C) Dbic 30- 35 mmol/L
  • Group 2: C) Dbic 30 -35 mmol/L B) Dbic 35- 30 mmol/L
  • Warsaw, Poland
    Wieliczko Monika
May 21, 2023

Pulmonary Hypertension Trial in Lexington (MK-5475, Placebo)

Recruiting
  • Pulmonary Hypertension
  • Lexington, Kentucky
    Lexington VA Medical Center - Cooper Division ( Site 0137)
Jan 8, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Pulmonary Hypertension Trial in Vienna (Aria CV Acute PH System)

Recruiting
  • Pulmonary Hypertension
  • Aria CV Acute PH System
  • Vienna, Austria
    Medical University of Vienna
Mar 14, 2022

High Grade Ovarian Cancer, Primary Peritoneal Cancer, Fallopian Tube Cancer Trial (Mirvetuximab soravtansine, Carboplatin)

Not yet recruiting
  • High Grade Ovarian Cancer
  • +2 more
  • (no location specified)
Jul 11, 2022

Pulmonary Hypertension Trial in Boston (LAM-001)

Recruiting
  • Pulmonary Hypertension
  • Boston, Massachusetts
    Brigham and Women's Hospital
Apr 11, 2023